These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 283285)
101. A new virus of minimal pathogenicity associated with Friend virus. I. Isolation by end-point dilution. Rowson KE; Parr IB Int J Cancer; 1970 Jan; 5(1):96-102. PubMed ID: 4313234 [No Abstract] [Full Text] [Related]
102. Porphobilinogen and porphyrin synthesis in splenomegaly of some murine leukemias. Fields LA; Vadlamudi S; Waravdekar VS; Goldin A Proc Soc Exp Biol Med; 1969 Feb; 130(2):372-6. PubMed ID: 5765267 [No Abstract] [Full Text] [Related]
103. Inhibition of DNA polymerases from RNA tumor viruses by tilorone and congeners: site of action. Chandra P; Will G; Gericke D; Götz A Biochem Pharmacol; 1974 Dec; 23(23):3259-65. PubMed ID: 4374214 [No Abstract] [Full Text] [Related]
104. Therapeutic activity of narcissus alkaloid on Rauscher leukemia and comparison with standard drugs. Furusawa E; Furusawa S; Morimoto S; Cutting W Proc Soc Exp Biol Med; 1971 Apr; 136(4):1168-73. PubMed ID: 5554461 [No Abstract] [Full Text] [Related]
105. Synthesis of histone H1(0) is not inhibited in hydroxyurea-treated Friend cells. Zlatanova JS FEBS Lett; 1980 Apr; 112(2):199-202. PubMed ID: 7371856 [No Abstract] [Full Text] [Related]
106. Synthesis of potential anticancer agents. 34. Fluorobenzimidazoles and fluorobenzotriazoles. Montgomery JA; Hewson K J Med Chem; 1965 Nov; 8(6):737-40. PubMed ID: 5894578 [No Abstract] [Full Text] [Related]
107. Effect of host strain and H-2 type on spontaneous regression of murine leukemia. Dietz M; Rich MA Int J Cancer; 1972 Jul; 10(1):99-104. PubMed ID: 4661563 [No Abstract] [Full Text] [Related]
108. Chromosomes in leukaemias induced by S37 and Friend viruses. WAKONIG-VAARTAJA R Br J Cancer; 1961 Mar; 15(1):120-2. PubMed ID: 13782606 [No Abstract] [Full Text] [Related]
109. Antivirion effects of streptovaricin complex against Friend virus. Horoszewicz JS; Leong SS; Byrd DM; Carter WA Antimicrob Agents Chemother; 1974 Nov; 6(5):594-7. PubMed ID: 15825311 [TBL] [Abstract][Full Text] [Related]
110. Structure and leukemogenic activity of a murine leukemia virus. De Tkaczevski L; De Harven E; Friend C J Virol; 1968 Apr; 2(4):365-75. PubMed ID: 5742040 [TBL] [Abstract][Full Text] [Related]
115. A simple method for obtaining highly viable virus from culture supernatant. Saha K; Lin YC; Wong PK J Virol Methods; 1994 Mar; 46(3):349-52. PubMed ID: 8006113 [TBL] [Abstract][Full Text] [Related]
116. Requirement of cellular DNA synthesis for the growth of Friend leukemia virus. Yoshikura H Exp Cell Res; 1968 Oct; 52(2):445-50. PubMed ID: 5693246 [No Abstract] [Full Text] [Related]
117. Antiviral effect of N-phenylacetoaminomethylene-DL-p-nitrophenylalanine (A-101) on murine leukemia viruses. Fujita H; Sakurai T; Toyoshima S J Natl Cancer Inst; 1979 Mar; 62(3):565-8. PubMed ID: 283285 [TBL] [Abstract][Full Text] [Related]
118. Antiviral effects of amino acid derivatives with the fluorene substituent on murine leukemia viruses. Fujita H; Toyoshima S J Natl Cancer Inst; 1983 Feb; 70(2):275-8. PubMed ID: 6571936 [TBL] [Abstract][Full Text] [Related]
119. Powerful new inhibitor of murine leukaemia and sarcoma viruses. Chermann JC; Raynaud M; Jasmin C; Mathé G Nature; 1970 Jul; 227(5254):173-4. PubMed ID: 4316954 [No Abstract] [Full Text] [Related]